HTGM News and Press, HTG Molecular Diagnostics Inc. From 04/07/22

Momentus MNTS +40% on signing launch service agreements with SpaceX. HTG Molecular Diagnostics (HTGM) +32% expands features of proprietary HTG EdgeSeq technology. ERYTECH Pharma ERYP +19% British Journal of Haematology publishes positive results from Erytech's phase 2...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today. Source: oneinchpunch/Shutterstock.com Pharmaceutical announcements, insider trading,...

TUCSON, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has improved the sample preparation protocol for its ...

TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released its first proof-of-approach white paper (the “White...

HTG Molecular Diagnostics, Inc. (HTGM) Q4 2021 Earnings Conference Call March 29, 2022 16:30 ET Corporate Participants Andrew Eriksen - IR, LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Rick Krause - Cantor Fitz...

HTG Molecular press release (NASDAQ:HTGM): FY GAAP EPS of -$2.47 misses by $0.10. Revenue of $8.91M (+4.2% Y/Y) in-line. Shares +0.63%. For further details see: HTG Molecular GAAP EPS of -$2.47 misses by $0.10, revenue of $8.91M in-line

TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial results for the year ended December 3...

AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...

HTG Molecular (NASDAQ:HTGM) is scheduled to announce FY earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$2.68 (+40.6% Y/Y) and the consensus Revenue Estimate is $8.91M (+4.2% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions a...

TUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the year ...